Select hyperacute complications of ischemic stroke: cerebral edema, hemorrhagic transformation, and orolingual angioedema secondary to intravenous Alteplase

References

• Castillo J. Deteriorating stroke: diagnostic criteria, predictors, mechanisms and treatment. Cerebrovasc Dis. 1999;9(3):1–8.
   PubMedGoogle Scholar
• Shah S, Kimberly WT. Today’s approach to treating brain swelling in the neuro intensive care unit. Semin Neurol. 2016;36:502–507.
   PubMed Web of Science ®Google Scholar
• Stokum JA, Kurland DB, Gerzanich V, et al. Mechanisms of astrocyte-mediated cerebral edema. Neurochem Res. 2015;40(2):317–328.
   PubMed Web of Science ®Google Scholar
• Banasiak KJ, Burenkova O, Haddad GG. Activation of voltage-sensitive sodium channels during oxygen deprivation leads to apoptotic neuronal death. Neuroscience. 2004;126(1):31–44.
   PubMed Web of Science ®Google Scholar
• Breder J, Sabelhaus CF, Opitz T, et al. Inhibition of different pathways influencing Na(+) homeostasis protects organotypic hippocampal slice cultures from hypoxic/hypoglycemic injury. Neuropharmacology. 2000;39(10):1779–1787.
   PubMed Web of Science ®Google Scholar
• Beck J, Lenart B, Kintner DB, et al. Na-K-Cl cotransporter contributes to glutamate-mediated excitotoxicity. J Neurosci. 2003;23(12):5061–5068.
   PubMed Web of Science ®Google Scholar
• Chen M, Simard JM. Cell swelling and a nonselective cation channel regulated by internal Ca2+ and ATP in native reactive astrocytes from adult rat brain. J Neurosci. 2001;21:6512–6521.
   PubMed Web of Science ®Google Scholar
• Simard JM, Chen M, Tarasov KV, et al. Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke. Nat Med. 2006;12:433–440.
   PubMed Web of Science ®Google Scholar
• Yang GY, Chen SF, Kinouchi H, et al. Edema, cation content, and ATPase activity after middle cerebral artery occlusion in rats. Stroke. 1992;23(9):1331–1336.
   PubMed Web of Science ®Google Scholar
• Mori K, Miyazaki M, Iwase H, et al. Temporal profile of changes in brain tissue extracellular space and extracellular ion (<ins style="background: springGreen">Na+, K+) concentrations after cerebral ischemia and the effects of mild cerebral hypothermia. J Neurotrauma. 2002;19(10):1261–1270.
   PubMed Web of Science ®Google Scholar
• Stiefel MF, Marmarou A. Cation dysfunction associated with cerebral ischemia followed by reperfusion: a comparison of microdialysis and ion-selective electrode methods. J Neurosurg. 2002;97(1):97–103.
   PubMed Web of Science ®Google Scholar
• Wang Y, Hu W, Perez-Trepichio AD, et al. Brain tissue sodium is a ticking clock telling time after arterial occlusion in rat focal cerebral ischemia. Stroke. 2000;31:1386–1391, discussion 92.
   PubMedGoogle Scholar
• Liu KF, Li F, Tatlisumak T, et al. Regional variations in the apparent diffusion coefficient and the intracellular distribution of water in rat brain during acute focal ischemia. Stroke. 2001;32(8):1897–1905.
   PubMed Web of Science ®Google Scholar
• Simard JM, Kent TA, Chen M, et al. Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol. 2007;6:258–268.
   PubMed Web of Science ®Google Scholar
• Todd NV, Picozzi P, Crockard A, et al. Duration of ischemia influences the development and resolution of ischemic brain edema. Stroke. 1986;17(3):466–471.
   PubMed Web of Science ®Google Scholar
• Gotoh O, Asano T, Koide T, et al. Ischemic brain edema following occlusion of the middle cerebral artery in the rat. I: the time courses of the brain water, sodium and potassium contents and blood-brain barrier permeability to 125I-albumin. Stroke. 1985;16:101–109.
   PubMed Web of Science ®Google Scholar
• von Kummer R, Dzialowski I. Imaging of cerebral ischemic edema and neuronal death. Neuroradiology. 2017;59:545–553.
   PubMed Web of Science ®Google Scholar
• Bier G, Bongers MN, Ditt H, et al. Enhanced gray-white matter differentiation on non-enhanced CT using a frequency selective non-linear blending. Neuroradiology. 2016;58(7):649–655.
   PubMed Web of Science ®Google Scholar
• Castejon OJ. Formation of transendothelial channels in traumatic human brain edema. Pathol Res Pract. 1984;179(1):7–12.
   PubMed Web of Science ®Google Scholar
• Brown RC, Davis TP. Calcium modulation of adherens and tight junction function: a potential mechanism for blood-brain barrier disruption after stroke. Stroke. 2002;33(5):1334–1339.
   PubMedGoogle Scholar
• Weis SM, Cheresh DA. Pathophysiological consequences of VEGF-induced vascular permeability. Nature. 2005;437(7058):497–504.
   PubMed Web of Science ®Google Scholar
• van Bruggen N, Thibodeaux H, Palmer JT, et al. VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J Clin Invest. 1999;104(11):1613–1620.
   PubMed Web of Science ®Google Scholar
• Li DD, Song JN, Huang H, et al. The roles of MMP-9/TIMP-1 in cerebral edema following experimental acute cerebral infarction in rats. Neurosci Lett. 2013;550:168–172.
   PubMed Web of Science ®Google Scholar
• Zhang HT, Zhang P, Gao Y, et al. Early VEGF inhibition attenuates blood-brain barrier disruption in ischemic rat brains by regulating the expression of MMPs. Mol Med Rep. 2017;15:57–64.
   PubMed Web of Science ®Google Scholar
• Hom S, Fleegal MA, Egleton RD, et al. Comparative changes in the blood-brain barrier and cerebral infarction of SHR and WKY rats. Am J Physiol Regul Integr Comp Physiol. 2007;292(3):R1129-36.
   PubMedGoogle Scholar
• Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017–1025.
   PubMed Web of Science ®Google Scholar
• Del Zoppo GJ, von Kummer R, Hamann GF. Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke. J Neurol Neurosurg Psychiatry. 1998;65(1):1–9.
   PubMed Web of Science ®Google Scholar
• Wang X, Tsuji K, Lee SR, et al. Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke. Stroke. 2004;35(11_suppl_1):2726–2730.
   PubMed Web of Science ®Google Scholar
• Jha R, Battey TW, Pham L, et al. Fluid-attenuated inversion recovery hyperintensity correlates with matrix metalloproteinase-9 level and hemorrhagic transformation in acute ischemic stroke. Stroke. 2014;45:1040–1045.
   PubMed Web of Science ®Google Scholar
• Chen F, Ohashi N, Li W, et al. Disruptions of occludin and claudin-5 in brain endothelial cells in vitro and in brains of mice with acute liver failure. Hepatology. 2009;50:1914–1923.
   PubMed Web of Science ®Google Scholar
• Rosell A, Cuadrado E, Ortega-Aznar A, et al. MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke. Stroke. 2008;39:1121–1126.
   PubMed Web of Science ®Google Scholar
• Berrouschot J, Sterker M, Bettin S, et al. Mortality of space-occupying (‘malignant’) middle cerebral artery infarction under conservative intensive care. Intensive Care Med. 1998;24(3):258–261.
   PubMedGoogle Scholar
• Asuzu D, Nystrom K, Sreekrishnan A, et al. TURN score predicts 24-hour cerebral edema after IV thrombolysis. Neurocrit Care. 2016;24:381–388.
   PubMed Web of Science ®Google Scholar
• Asuzu D, Nystrom K, Amin H, et al. TURN: a simple predictor of symptomatic intracerebral hemorrhage after IV thrombolysis. Neurocrit Care. 2015;23:166–71.
   PubMed Web of Science ®Google Scholar
• Ong CJ, Gluckstein J, Laurido-Soto O, et al. Enhanced detection of Edema in Malignant Anterior Circulation Stroke (EDEMA) score: a risk prediction tool. Stroke. 2017;48:1969–72.
   PubMed Web of Science ®Google Scholar
• Thomalla G, Hartmann F, Juettler E, et al. Prediction of malignant middle cerebral artery infarction by magnetic resonance imaging within 6 hours of symptom onset: A prospective multicenter observational study. Ann Neurol. 2010;68:435–445.
   PubMed Web of Science ®Google Scholar
• Kruetzelmann A, Hartmann F, Beck C, et al. Combining magnetic resonance imaging within six-hours of symptom onset with clinical follow-up at 24 h improves prediction of ‘malignant’ middle cerebral artery infarction. Int J Stroke. 2014;9:210–214.
   PubMed Web of Science ®Google Scholar
• Seet RC, Rabinstein AA. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions. Cerebrovasc Dis. 2012;34(2):106–114.
   PubMed Web of Science ®Google Scholar
• Yaghi S, Willey JZ, Cucchiara B, et al. Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2017;48:e343-e361.
   PubMed Web of Science ®Google Scholar
• Lees KR, Bluhmki E, von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;375(9727):1695–1703.
   PubMed Web of Science ®Google Scholar
• Terruso V, D’Amelio M, Di Benedetto N, et al. Frequency and determinants for hemorrhagic transformation of cerebral infarction. Neuroepidemiology. 2009;33(3):261–265.
   PubMed Web of Science ®Google Scholar
• Tan S, Wang D, Liu M, et al. Frequency and predictors of spontaneous hemorrhagic transformation in ischemic stroke and its association with prognosis. J Neurol. 2014;261(1):164–173.
   PubMedGoogle Scholar
• James B, Chang AD, McTaggart RA, et al. Predictors of symptomatic intracranial haemorrhage in patients with an ischaemic stroke with neurological deterioration after intravenous thrombolysis. J Neurol Neurosurg Psychiatry. 2018;89:866–869.
   PubMed Web of Science ®Google Scholar
• Strbian D, Engelter S, Michel P, et al. Symptomatic intracranial hemorrhage after stroke thrombolysis: the SEDAN score. Ann Neurol. 2012;71(5):634–641.
   PubMed Web of Science ®Google Scholar
• Lou M, Safdar A, Mehdiratta M, et al. The HAT Score: a simple grading scale for predicting hemorrhage after thrombolysis. Neurology. 2008;71(18):1417–1423.
   PubMed Web of Science ®Google Scholar
• Cucchiara B, Tanne D, Levine SR, et al. A risk score to predict intracranial hemorrhage after recombinant tissue plasminogen activator for acute ischemic stroke. J Stroke Cerebrovasc Dis. 2008;17(6):331–333.
   PubMedGoogle Scholar
• Menon BK, Saver JL, Prabhakaran S, et al. Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator. Stroke. 2012;43(9):2293–2299.
   PubMed Web of Science ®Google Scholar
• Mazya M, Egido JA, Ford GA, et al. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score. Stroke. 2012;43(6):1524–1531.
   PubMed Web of Science ®Google Scholar
• Saposnik G, Fang J, Kapral MK, et al. The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke. Stroke. 2012;43(5):1315–1322.
   PubMed Web of Science ®Google Scholar
• Shi ZS, Duckwiler GR, Jahan R, et al. Early blood-brain barrier disruption after mechanical thrombectomy in acute ischemic stroke. J Neuroimaging. 2018;28(3):283–288.
   PubMed Web of Science ®Google Scholar
• Curley G, Kavanagh BP, Laffey JG. Hypocapnia and the injured brain: evidence for harm. Crit Care Med. 2011;39(1):229–230.
   PubMed Web of Science ®Google Scholar
• Bevers MB, Kimberly WT. Critical care management of acute ischemic stroke. Curr Treat Options Cardiovasc Med. 2017;19:41.
   PubMedGoogle Scholar
• Dorman HR, Sondheimer JH, Cadnapaphornchai P. Mannitol-induced acute renal failure. Medicine (Baltimore). 1990;69(3):153–159.
   PubMed Web of Science ®Google Scholar
• Fink ME. Osmotherapy for intracranial hypertension: mannitol versus hypertonic saline. Continuum (Minneap Minn). 2012;18:640–54.
   PubMedGoogle Scholar
• Kaufmann AM, Cardoso ER. Aggravation of vasogenic cerebral edema by multiple-dose mannitol. J Neurosurg. 1992;77(4):584–589.
   PubMed Web of Science ®Google Scholar
• Ryu JH, Walcott BP, Kahle KT, et al. Induced and sustained hypernatremia for the prevention and treatment of cerebral edema following brain injury. Neurocrit Care. 2013;19(2):222–231.
   PubMed Web of Science ®Google Scholar
• Hauer EM, Stark D, Staykov D, et al. Early continuous hypertonic saline infusion in patients with severe cerebrovascular disease. Crit Care Med. 2011;39(7):1766–1772.
   PubMed Web of Science ®Google Scholar
• Aiyagari V, Deibert E, Diringer MN. Hypernatremia in the neurologic intensive care unit: how high is too high? J Crit Care. 2006;21(2):163–172.
   PubMed Web of Science ®Google Scholar
• Huang L, Cao W, Deng Y, et al. Hypertonic saline alleviates experimentally induced cerebral oedema through suppression of vascular endothelial growth factor and its receptor VEGFR2 expression in astrocytes. BMC Neurosci. 2016;17:64.
   PubMed Web of Science ®Google Scholar
• Zornow MH. Hypertonic saline as a safe and efficacious treatment of intracranial hypertension. J Neurosurg Anesthesiol. 1996;8(2):175–177.
   PubMed Web of Science ®Google Scholar
• Suarez JI, Qureshi AI, Bhardwaj A, et al. Treatment of refractory intracranial hypertension with 23.4% saline. Crit Care Med. 1998;26:1118–1122.
   PubMed Web of Science ®Google Scholar
• Kamel H, Navi BB, Nakagawa K, et al. Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: a meta-analysis of randomized clinical trials. Crit Care Med. 2011;39(3):554–559.
   PubMed Web of Science ®Google Scholar
• Mortazavi MM, Romeo AK, Deep A, et al. Hypertonic saline for treating raised intracranial pressure: literature review with meta-analysis. J Neurosurg. 2012;116:210–221.
   PubMed Web of Science ®Google Scholar
• Jones GM, Bode L, Riha H, et al. Safety of continuous peripheral infusion of 3% sodium chloride solution in neurocritical care patients. Am J Crit Care. 2016;26:37–42.
   PubMed Web of Science ®Google Scholar
• Froelich M, Ni Q, Wess C, et al. Continuous hypertonic saline therapy and the occurrence of complications in neurocritically ill patients. Crit Care Med. 2009;37(11):2905–2912.
   PubMedGoogle Scholar
• Schwarz S, Schwab S, Bertram M, et al. Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke. 1998;29(10):2069–2072.
   PubMedGoogle Scholar
• Lewandowski-Belfer JJ, Patel AV, Darracott RM, et al. Safety and efficacy of repeated doses of 14.6 or 23.4 % hypertonic saline for refractory intracranial hypertension. Neurocrit Care. 2014;20:436–442.
   PubMed Web of Science ®Google Scholar
• Sheth KN, Elm JJ, Molyneaux BJ, et al. Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurol. 2016;15:1160–1169.
   PubMed Web of Science ®Google Scholar
• Walcott BP, Kahle KT, Simard JM. Novel treatment targets for cerebral edema. Neurotherapeutics. 2012;9(1):65–72.
   PubMed Web of Science ®Google Scholar
• Yan Y, Dempsey RJ, Sun D. <ins style="background: springGreen">Na + -K + -<ins style="background: springGreen">Cl − cotransporter in rat focal cerebral ischemia. J Cereb Blood Flow Metab. 2001;21(6):711–721.
   PubMedGoogle Scholar
• Yan Y, Dempsey RJ, Flemmer A, et al. Inhibition of Na(+)-K(+)-Cl(-) cotransporter during focal cerebral ischemia decreases edema and neuronal damage. Brain Res. 2003;961(1):22–31.
   PubMed Web of Science ®Google Scholar
• Raco A, Caroli E, Isidori A, et al. Management of acute cerebellar infarction: one institution’s experience. Neurosurgery. 2003;53:1061–1066, discussion 5-6.
   PubMed Web of Science ®Google Scholar
• Kudo H, Kawaguchi T, Minami H, et al. Controversy of surgical treatment for severe cerebellar infarction. J Stroke Cerebrovasc Dis. 2007;16(6):259–262.
   PubMedGoogle Scholar
• Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018;49:e46–e110.
   PubMed Web of Science ®Google Scholar
• Crudele A, Shah SO, Bar B. Decompressive hemicraniectomy in acute neurological diseases. J Intensive Care Med. 2016;31(9):587–596.
   PubMed Web of Science ®Google Scholar
• Vahedi K, Vicaut E, Mateo J, et al. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke. 2007;38(9):2506–2517.
   PubMed Web of Science ®Google Scholar
• Juttler E, Schwab S, Schmiedek P, et al. Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial. Stroke. 2007;38(9):2518–2525.
   PubMed Web of Science ®Google Scholar
• Hofmeijer J, Kappelle LJ, Algra A, et al. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol. 2009;8(4):326–333.
   PubMed Web of Science ®Google Scholar
• Vahedi K, Hofmeijer J, Juettler E, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007;6:215–222.
   PubMed Web of Science ®Google Scholar
• Zhao J, Su YY, Zhang Y, et al. Decompressive hemicraniectomy in malignant middle cerebral artery infarct: a randomized controlled trial enrolling patients up to 80 years old. Neurocrit Care. 2012;17:161–171.
   PubMed Web of Science ®Google Scholar
• Juttler E, Bosel J, Amiri H, et al. DESTINY II: dEcompressive Surgery for the Treatment of malignant INfarction of the middle cerebral arterY II. Int J Stroke. 2011;6(1):79–86.
   PubMed Web of Science ®Google Scholar
• Hwang DY, Matouk CC, Sheth KN. Management of the malignant middle cerebral artery syndrome. Semin Neurol. 2013;33:448–55.
   PubMed Web of Science ®Google Scholar
• Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46:2032–2060.
   PubMed Web of Science ®Google Scholar
• Switzer JA, Hess DC, Ergul A, et al. Matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute ischemic stroke. Stroke. 2011;42:2633–2635.
   PubMed Web of Science ®Google Scholar
• Chaturvedi M, Figiel I, Sreedhar B, et al. Neuroprotection from tissue inhibitor of metalloproteinase-1 and its nanoparticles. Neurochem Int. 2012;61:1065–1071.
   PubMed Web of Science ®Google Scholar
• Su EJ, Fredriksson L, Geyer M, et al. Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med. 2008;14(7):731–737.
   PubMed Web of Science ®Google Scholar
• Sifat AE, Vaidya B, Abbruscato TJ. Blood-brain barrier protection as a therapeutic strategy for acute ischemic stroke. Aaps J. 2017;19:957–972.
   PubMed Web of Science ®Google Scholar
• Correia AS, Matias G, Calado S, et al. Orolingual angiodema associated with alteplase treatment of acute stroke: a reappraisal. J Stroke Cerebrovasc Dis. 2015;24(10):2207–2212.
   PubMedGoogle Scholar
• Brown E, Campana C, Zimmerman J, et al. Icatibant for the treatment of orolingual angioedema following the administration of tissue plasminogen activator. Am J Emerg Med. 2018;36:1125.e1-1125.e2.
   Web of Science ®Google Scholar